$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
恩杂鲁胺效果怎么样?
2025-10-19 11:44:20
Check Details
阿斯利康康士得一盒可以吃几天?
2025-10-19 11:44:20
Check Details
阿斯利康康士得购买途径
2025-10-19 11:44:20
Check Details
阿斯利康康士得去哪可以买到?
2025-10-19 11:44:20
Check Details
阿斯利康康士得治疗前列腺癌的效果好吗?
2025-10-19 11:44:20
Check Details
阿斯利康康士得每天什么时候吃最好?
2025-10-19 11:44:20
Check Details
阿斯利康康士得大概吃多久会耐药?
2025-10-19 11:44:20
Check Details
阿斯利康康士得吃多久能停?
2025-10-19 11:44:20
Check Details
英国阿斯利康康士得价格及规格
2025-10-19 11:44:20
Check Details
泽珂医保报销比例
2025-10-19 11:44:20
Check Details
泽珂医保能报销吗
2025-10-19 11:44:20
Check Details
泽珂用法用量
2025-10-19 11:44:20
Check Details
1
2
...
1525
1526
1527
1528
1529
1530
1531
...
4158
4159
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
2
Lapatinib: Proper Administration Guide and Key Precautions
3
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
4
Cemiplimab Storage and Handling Guide
5
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Dosing Duration, Efficacy Comparison, and Long-Term Management
6
Belzutifan (Welireg): Comprehensive Guide to the First HIF-2α Inhibitor — Indications, Dosing, and Safety Monitoring
7
Encorafenib (Braftovi): Comprehensive Guide to BRAF V600 Inhibitor Indications, Dose Regimens by Tumor Type, and Administration Requirements
8
Alpelisib vs Inavolisib: How to Choose Between Two PI3Kα Inhibitors in PIK3CA-Mutated Breast Cancer
9
Selumetinib: The First MEK1/2 Inhibitor Approved for Inoperable Plexiform Neurofibromas in NF1
10
FIGHT-302 Phase 3 Trial: First-Line Pemigatinib Significantly Improves PFS Over Chemotherapy in FGFR2-Rearranged Cholangiocarcinoma
11
Selpercatinib Dosing Guide: Weight-Based Precision Targeting for RET-Driven Tumors
12
Mitotane Side Effects: Understanding Key Risks in Adrenocortical Carcinoma Therapy